Detalhe da pesquisa
1.
Structural basis for selective small molecule kinase inhibition of activated c-Met.
J Biol Chem
; 286(13): 11218-25, 2011 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-21247903
2.
Discovery of 1-[3-(1-methyl-1H-pyrazol-4-yl)-5-oxo-5H-benzo[4,5]cyclohepta[1,2-b]pyridin-7-yl]-N-(pyridin-2-ylmethyl)methanesulfonamide (MK-8033): A Specific c-Met/Ron dual kinase inhibitor with preferential affinity for the activated state of c-Met.
J Med Chem
; 56(6): 2294-310, 2013 Mar 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-23379595
3.
Discovery of a 5H-benzo[4,5]cyclohepta[1,2-b]pyridin-5-one (MK-2461) inhibitor of c-Met kinase for the treatment of cancer.
J Med Chem
; 54(12): 4092-108, 2011 Jun 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-21608528
4.
Asymmetric azidation-cycloaddition with open-chain peptide-based catalysts. A sequential enantioselective route to triazoles.
J Am Chem Soc
; 124(10): 2134-6, 2002 Mar 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-11878965
5.
Nucleophilic chiral amines as catalysts in asymmetric synthesis.
Chem Rev
; 103(8): 2985-3012, 2003 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-12914489